Wieneke M T van den Hombergh (Wieneke Mt van den Hombergh, W M T van den Hombergh)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Systemic Sclerosis

Coronary Artery

Top Venues

Journal of scleroderma and related disorders

Rheumatology (Oxford, England)

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Brigit E Kersten, Jacqueline M J Lemmers, Amber Vanhaecke, Arthiha Velauthapillai, Wieneke M T van den Hombergh, Frank H J van den Hoogen, Cornelia H M van den Ende, Vanessa Smith, Madelon C Vonk
Efficacy of methylprednisolone in very early systemic sclerosis: results of the "Hit hard and early'' randomized controlled trial. Rheumatology (Oxford, England) (2024)
Wieneke M T van den Hombergh, Hanneke Ka Knaapen-Hans, Frank Hj van den Hoogen, Patricia Carreira, Oliver Distler, Roger Hesselstrand, Nicolas Hunzelmann, Serena Vettori, Jaap Fransen, Madelon C Vonk
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis. Journal of scleroderma and related disorders 5 (1) (2019)
Wieneke M T van den Hombergh, S O Simons, E Teesselink, H K A Knaapen-Hans, F H J van den Hoogen, J Fransen, M C Vonk
Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function. Clinical rheumatology 37 (10) (2018)
Wieneke M T van den Hombergh, Brigit E Kersten, Hanneke K A Knaapen-Hans, Rogier M Thurlings, Peter M van der Kraan, Frank H J van den Hoogen, Jaap Fransen, Madelon C Vonk
Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial. Trials 19 (1) (2018)